Alembic rolls out generic Prolensa
Bromfenac ophthalmic solution is a nonsteroidal anti-inflammatory drug indicated for postoperative inflammation in patients who have undergone cataract surgery.
Alembic is releasing bromfenac ophthalmic solution 0.07%, which is the generic of Bausch & Lomb's Prolensa.
Bromfenac pphthalmic solution is a nonsteroidal anti-inflammatory drug indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
[Read more: Alembic releases generic Pradaxa]
Alembic is offering bromfenac ophthalmic solution 0.07% in a 3 ml bottle.